TickerFactsScreenerDevelopers

Keros Therapeutics, Inc. (KROS) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2019: $271.0K2020: $294.0K2021: $1.02M2022: $1.24M2023: $2.46M2024: $1.93M2025: $1.55M$1.55M
2019Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$1.55M-19.7%
2024$1.93M-21.6%
2023$2.46M+98.5%
2022$1.24M+21.2%
2021$1.02M+248.3%
2020$294.0K+8.5%
2019$271.0K—